Receptors for the neuropeptides VIP and P ACAP belong to a novel sub-family of G protein-coupled receptors, the secretin/ calcitonin/ parathyroid hormone receptor family. The rat VIP2 receptor was recently cloned in this laboratory and the present project was carried out to characterise the signalling mechanisms used by this receptor and define the role of crucial receptor domains. These studies have primarily involved the transient expression of receptors in host cells. The results demonstrated for the first time that both the VIP1 and VIP2 receptors can stimulate phospholipase C (PLC) in addition to adenylate cyclase (AC) and that this stimulation occurs by a pertussis toxin(PTx)-sensitive mechanism. Correspondingly, GTP,.S modu...
The 28-amino-acid neuropeptide VIP and related peptides PACAP and PHI/PHM modulate virtually all of ...
The effects of vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase-activating po...
The affinity and specificity of the binding interaction between ligands and their receptors are key ...
AbstractWe have cloned and sequenced a cDNA (RPR4) encoding a new member of the secretin/calcitonin/...
AbstractThe PACAP receptor (PACAP I receptor, selective for PACAP) and the PACAP II VIP1 receptor (r...
AbstractThe structural requirements of vasoactive intestinal polypeptide (VIP) for receptor binding ...
AbstractThe seven-transmembrane (7TM) G-protein-coupled neuroendocrine receptors VPAC1 (HGNC approve...
Receptors for the neurotransmitter and neuroendocrine peptides, vasoactive intesinal peptide (VIP) a...
Homeostasis of the human immune system is regulated by many cellular components, including two neuro...
AbstractThe VPAC2 (vasoactive intestinal peptide (VIP)2) receptor is a seven-transmembrane spanning ...
The present review is focused on the exocrine pancreas and liver where the only known effector mecha...
Pituitary adenylate cyclase-activating polypeptide (PACAP, gene name ADCYAP1) is a multifunctional n...
The stimulatory effect of vasoactive intestinal peptide (VIP) on the intracellular calcium concentra...
At the time of its isolation, purification and sequencing in 1970-1972 by Said and Mutt (Said and Mu...
© 2017 The British Pharmacological SocietyBackground and purpose: Vasoactive intestinal peptide (VIP...
The 28-amino-acid neuropeptide VIP and related peptides PACAP and PHI/PHM modulate virtually all of ...
The effects of vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase-activating po...
The affinity and specificity of the binding interaction between ligands and their receptors are key ...
AbstractWe have cloned and sequenced a cDNA (RPR4) encoding a new member of the secretin/calcitonin/...
AbstractThe PACAP receptor (PACAP I receptor, selective for PACAP) and the PACAP II VIP1 receptor (r...
AbstractThe structural requirements of vasoactive intestinal polypeptide (VIP) for receptor binding ...
AbstractThe seven-transmembrane (7TM) G-protein-coupled neuroendocrine receptors VPAC1 (HGNC approve...
Receptors for the neurotransmitter and neuroendocrine peptides, vasoactive intesinal peptide (VIP) a...
Homeostasis of the human immune system is regulated by many cellular components, including two neuro...
AbstractThe VPAC2 (vasoactive intestinal peptide (VIP)2) receptor is a seven-transmembrane spanning ...
The present review is focused on the exocrine pancreas and liver where the only known effector mecha...
Pituitary adenylate cyclase-activating polypeptide (PACAP, gene name ADCYAP1) is a multifunctional n...
The stimulatory effect of vasoactive intestinal peptide (VIP) on the intracellular calcium concentra...
At the time of its isolation, purification and sequencing in 1970-1972 by Said and Mutt (Said and Mu...
© 2017 The British Pharmacological SocietyBackground and purpose: Vasoactive intestinal peptide (VIP...
The 28-amino-acid neuropeptide VIP and related peptides PACAP and PHI/PHM modulate virtually all of ...
The effects of vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase-activating po...
The affinity and specificity of the binding interaction between ligands and their receptors are key ...